SCHEMBL23013299

SCHEMBL23013299

CCOC(=O)c1c(-c2ccccc2F)nn2ccc(N3C[C@H]4C[C@@H]3CN4C)nc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ DGAT1 O75907 1/20 0.36
▸ SOAT1 P35610 1/20 0.36
▸ PARP1 P09874 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ ALOX5 P09917 2/20 0.35
▸ JAK2 O60674 1/20 0.35
▸ JAK3 P52333 1/20 0.35
▸ TP53 P04637 1/20 0.34
▸ POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29692241 1.00 KMT2A (0.36) KMT2AALDH1A1HSD17B10KDM4EMEN1
SCHEMBL23023665 0.82 PARP1 (0.37) ALDH1A1MAPK1PARP1SMN1; SMN2GRK6
SCHEMBL29939181 0.81 DGAT1 (0.45) KMT2AALDH1A1HSD17B10KDM4EMEN1
SCHEMBL25150706 0.81 DGAT1 (0.45) KMT2AALDH1A1HSD17B10KDM4EMEN1
SCHEMBL29703797 0.79 ALDH1A1 (0.44) KMT2AALDH1A1HSD17B10KDM4EMEN1
SCHEMBL23013511 0.79 ALDH1A1 (0.44) KMT2AALDH1A1HSD17B10KDM4EMEN1
SCHEMBL29939586 0.78 DGAT1 (0.55) DGAT1SOAT1
SCHEMBL25150512 0.78 DGAT1 (0.55) DGAT1SOAT1
SCHEMBL23013341 0.75 NOTCH1 (0.43) —
SCHEMBL29939563 0.73 JAK2 (0.47) KMT2AALDH1A1HSD17B10KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12227507-B2 Pharmaceutical compounds PFIZER INC. (US) 2025-02-18 — — US disclosed
US-11634425-B2 Pharmaceutical compounds PFIZER INC. (US) 2023-04-25 — — US disclosed
US-20220324873-A1 PHARMACEUTICAL COMPOUNDS PFIZER INC. 2022-10-13 — — US disclosed
US-20220306639-A1 PHARMACEUTICAL COMPOUNDS PFIZER INC. 2022-09-29 — — US disclosed
EP-4017856-A1 PHARMACEUTICAL COMPOUNDS Reviral Limited (GB) 2022-06-29 — — EP disclosed
WO-2021032992-A1 PHARMACEUTICAL COMPOUNDS ReViral Limited (GB) 2021-02-25 — — WO disclosed
WO-2021032992-A1 PHARMACEUTICAL COMPOUNDS ReViral Limited (GB) 2021-02-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12227507-B2 Pharmaceutical compounds CHRNA6, GABRA6, CHRNA7 KMT2A 3557/4885ALDH1A1 3480/4885HSD17B10 1912/4885
US-11634425-B2 Pharmaceutical compounds GABRA6, CHRNA6, CNR1 KMT2A 3408/4885ALDH1A1 3010/4885HSD17B10 1630/4885
US-20220306639-A1 PHARMACEUTICAL COMPOUNDS CHRNA6, GABRA6, CHRNA7 KMT2A 3557/4885ALDH1A1 3480/4885HSD17B10 1912/4885
US-20220324873-A1 PHARMACEUTICAL COMPOUNDS GABRA6, CNR1, CHRNA6 KMT2A 3193/4885ALDH1A1 3112/4885HSD17B10 1875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback